Pharmacology Quiz: Adrenergic Antagonists
20 questions · exam conditions
0:00
Adrenergic AntagonistsQuestion 1 of 20

A patient with hypertension and baseline sinus bradycardia (heart rate 50 bpm) requires treatment with a beta-blocker. Which of the following agents might be preferred due to a mechanism that lessens the severity of bradycardia compared to other drugs in its class?

Pindolol, due to its intrinsic sympathomimetic activity.
Carvedilol, due to its additional alpha-1 blocking properties.
Atenolol, due to its high selectivity for beta-1 receptors.
Nebivolol, due to its nitric oxide-potentiating effects.
← Back to quizzes

Pharmacology Quiz

Pharmacology Quiz: Adrenergic Antagonists

Practice Adrenergic Antagonists in Pharmacology with focused quiz questions that help you check what you know, review explanations, and build confidence with test-style prompts.

What this quiz covers

This quiz focuses on Adrenergic Antagonists, giving you a quick way to practice the rules, question types, and explanations that matter most for Pharmacology.

How to use this quiz

Try each quiz question before looking at the correct answer. Use the explanations to review missed ideas, then come back to similar questions until the pattern feels familiar.

All questions

Question 1

A patient with hypertension and baseline sinus bradycardia (heart rate 50 bpm) requires treatment with a beta-blocker. Which of the following agents might be preferred due to a mechanism that lessens the severity of bradycardia compared to other drugs in its class?

  1. Pindolol, due to its intrinsic sympathomimetic activity. (correct answer)
  2. Carvedilol, due to its additional alpha-1 blocking properties.
  3. Atenolol, due to its high selectivity for beta-1 receptors.
  4. Nebivolol, due to its nitric oxide-potentiating effects.
Explanation: Pindolol is a non-selective beta-blocker with intrinsic sympathomimetic activity (ISA). This means it is a partial agonist. At rest, when sympathetic tone is low, pindolol provides a low level of receptor stimulation, which can prevent severe bradycardia or a drop in cardiac output. During exercise, when sympathetic tone is high, it acts as a competitive antagonist. This property makes it a potential choice for patients who develop symptomatic bradycardia on other beta-blockers.

Question 2

A patient in anaphylactic shock receives an intravenous injection of epinephrine, which increases their blood pressure from 70/40 mmHg to 140/90 mmHg. If a non-selective alpha-adrenergic antagonist like phentolamine is then administered, what is the most probable effect on the patient's blood pressure?

  1. A further increase in systolic blood pressure due to reflex tachycardia.
  2. A decrease in diastolic pressure but a maintained or increased systolic pressure.
  3. A profound decrease in blood pressure, potentially falling below the initial baseline. (correct answer)
  4. Stabilization of blood pressure near the pre-epinephrine baseline of 70/40 mmHg.
Explanation: This scenario describes 'epinephrine reversal'. Epinephrine stimulates alpha-1, beta-1, and beta-2 receptors. The alpha-1 stimulation causes vasoconstriction (increasing BP), while beta-2 stimulation causes vasodilation (decreasing BP). After an alpha-blocker is given, the alpha-1 vasoconstrictor effect is blocked, leaving the beta-2 vasodilator effect unopposed. This results in a significant drop in blood pressure.

Question 3

A 65-year-old male with benign prostatic hyperplasia (BPH) and hypertension is started on prazosin. After taking the first dose at bedtime, he feels dizzy and faints when he gets up during the night to use the restroom. This adverse event is primarily caused by the drug's antagonism of alpha-1 receptors located on which tissue?

  1. Arteriolar smooth muscle, causing a precipitous drop in systemic vascular resistance.
  2. Venous smooth muscle, leading to decreased venous return and preload. (correct answer)
  3. The trigone and sphincter of the bladder, causing acute urinary retention.
  4. The radial muscle of the iris, leading to miosis and blurred vision.
Explanation: The 'first-dose' orthostatic hypotension associated with alpha-1 blockers like prazosin is primarily due to the blockade of alpha-1 receptors on venous capacitance vessels. This leads to venodilation, pooling of blood in the periphery, decreased venous return to the heart (preload), and a subsequent drop in cardiac output and blood pressure upon standing.

Question 4

A patient abruptly discontinues long-term therapy with high-dose metoprolol. Over the next 24-48 hours, they develop angina, palpitations, and severe hypertension. This withdrawal syndrome is best explained by which of the following physiological adaptations?

  1. Downregulation of presynaptic alpha-2 adrenergic autoreceptors.
  2. Increased plasma concentration of circulating catecholamines.
  3. Upregulation and increased sensitivity of beta-1 adrenergic receptors. (correct answer)
  4. Decreased metabolic clearance of endogenous norepinephrine.
Explanation: Chronic blockade of beta-adrenergic receptors leads to a compensatory increase in the number and sensitivity of these receptors on target tissues (upregulation). When the antagonist is suddenly withdrawn, the receptors are hyper-responsive to endogenous catecholamines (epinephrine, norepinephrine), leading to an exaggerated sympathetic response, including tachycardia, increased contractility, and hypertension.

Question 5

A 45-year-old patient with type 1 diabetes and essential hypertension is prescribed propranolol. Which of the following represents the most significant acute risk for this specific patient related to the medication's mechanism of action?

  1. Development of hyperosmolar hyperglycemic state due to impaired insulin release.
  2. Masking of neurogenic warning symptoms of hypoglycemia, such as tachycardia and tremors. (correct answer)
  3. Potentiation of metformin's action, leading to an increased risk of lactic acidosis.
  4. Worsening of diabetic nephropathy due to reduced renal blood flow.
Explanation: Non-selective beta-blockers like propranolol block the adrenergic response to hypoglycemia. Symptoms like tachycardia, palpitations, and tremors, which serve as crucial warning signs for a diabetic patient, are blunted. While sweating (a cholinergic symptom) is preserved, the loss of other key symptoms increases the risk of severe, unrecognized hypoglycemic episodes.

Question 6

A 59-year-old male with hypertension has been treated with metoprolol tartrate for five years. His recent fasting lipid panel reveals a triglyceride level of 250 mg/dL and an HDL level of 35 mg/dL. These findings represent a known metabolic adverse effect pattern associated with beta-blocker therapy. Which subset of beta-antagonists is most strongly associated with these particular lipid abnormalities?

  1. Agents with intrinsic sympathomimetic activity like pindolol.
  2. Beta-1 selective antagonists like metoprolol.
  3. Alpha-1 and beta-antagonists like carvedilol.
  4. Non-selective beta-antagonists like propranolol. (correct answer)
Explanation: When you encounter questions about beta-blocker side effects, remember that different subtypes of beta-antagonists have distinct metabolic profiles, particularly regarding lipid metabolism. The patient's lipid abnormalities—elevated triglycerides (250 mg/dL) and low HDL (35 mg/dL)—represent a classic adverse metabolic pattern. This occurs because beta-2 receptors normally promote lipolysis and help maintain favorable lipid profiles. When these receptors are blocked, triglyceride clearance decreases and HDL levels drop. Non-selective beta-antagonists like propranolol (D) block both beta-1 and beta-2 receptors throughout the body. The beta-2 blockade in adipose tissue and liver significantly impairs lipid metabolism, making this class most strongly associated with the described lipid abnormalities. This is the correct answer. Looking at the distractors: (A) Agents with intrinsic sympathomimetic activity like pindolol actually have less pronounced metabolic effects because they provide partial beta-receptor stimulation, somewhat offsetting the negative lipid effects. (B) Beta-1 selective antagonists like metoprolol (ironically, what this patient is taking) primarily affect cardiac beta-1 receptors and have minimal impact on beta-2-mediated lipid metabolism. (C) Alpha-1 and beta-antagonists like carvedilol often improve lipid profiles due to their alpha-blocking properties, which can enhance insulin sensitivity. Study tip: Remember the selectivity spectrum—the more non-selective the beta-blocker (especially affecting beta-2 receptors), the greater the risk of metabolic side effects. Always consider switching to beta-1 selective agents or those with additional alpha-blocking properties when lipid abnormalities develop.

Question 7

A 68-year-old patient with heart failure with reduced ejection fraction (HFrEF) is being treated with carvedilol. Compared to a beta-1 selective antagonist like metoprolol succinate, what additional hemodynamic benefit does carvedilol provide in this patient population?

  1. Greater reduction in heart rate due to higher affinity for beta-1 receptors.
  2. Afterload reduction through blockade of vascular alpha-1 receptors. (correct answer)
  3. Prevention of bradycardia through intrinsic sympathomimetic activity.
  4. Enhanced renal perfusion by blocking beta-2 receptors in the kidney.
Explanation: Carvedilol is a non-selective beta-blocker that also possesses alpha-1 blocking activity. This alpha-1 antagonism leads to vasodilation, which reduces systemic vascular resistance (afterload). This reduction in afterload decreases the work the failing heart must do to eject blood, providing a hemodynamic advantage over beta-blockers that lack this property, like metoprolol.

Question 8

A 30-year-old pregnant patient at 32 weeks gestation presents with a blood pressure of 180/115 mmHg and is diagnosed with a hypertensive emergency. Intravenous labetalol is administered. The therapeutic advantage of labetalol in this setting stems from its ability to:

  1. selectively block beta-1 receptors, lowering cardiac output without affecting uterine tone.
  2. decrease systemic vascular resistance via alpha-1 blockade while preventing reflex tachycardia via beta-blockade. (correct answer)
  3. act as a direct-acting arterial vasodilator, bypassing adrenergic receptors entirely.
  4. stimulate central alpha-2 receptors, reducing sympathetic outflow from the brainstem.
Explanation: Labetalol is a mixed antagonist with a blocking ratio of approximately 1:7 for alpha-1 to beta receptors after IV administration. The alpha-1 blockade causes vasodilation, lowering systemic vascular resistance and blood pressure. The simultaneous beta-blockade (both beta-1 and beta-2) prevents the baroreceptor-mediated reflex tachycardia that would typically occur with a pure vasodilator, making it an effective and hemodynamically stable choice in hypertensive emergencies.

Question 9

A 34-year-old woman being treated with propranolol for migraine prophylaxis complains of vivid nightmares, fatigue, and difficulty concentrating. Which pharmacokinetic property of propranolol is most responsible for these adverse effects?

  1. High degree of plasma protein binding.
  2. Extensive first-pass hepatic metabolism.
  3. High lipid solubility (lipophilicity). (correct answer)
  4. Renal excretion of active metabolites.
Explanation: Propranolol is highly lipophilic, which allows it to readily cross the blood-brain barrier and enter the central nervous system. Its presence in the CNS is responsible for adverse effects such as fatigue, depression, sleep disturbances, and nightmares. More hydrophilic beta-blockers (e.g., atenolol) have less CNS penetration and are associated with fewer of these side effects.

Question 10

A 72-year-old patient on metoprolol succinate for heart failure and verapamil for atrial fibrillation is admitted with lightheadedness and a heart rate of 35 bpm. The electrocardiogram shows a third-degree atrioventricular (AV) block. This severe adverse event is a result of the synergistic effects of these two drugs on which physiological process?

  1. Inhibition of the funny current (If) in the sinoatrial node.
  2. Blockade of fast sodium channels in ventricular myocytes.
  3. Suppression of calcium influx and conduction velocity in the AV node. (correct answer)
  4. Potentiation of vagal tone at the sinoatrial node.
Explanation: Both beta-blockers (like metoprolol) and non-dihydropyridine calcium channel blockers (like verapamil) suppress AV nodal conduction. Beta-blockers do this by decreasing cAMP, which reduces calcium current. Verapamil directly blocks L-type calcium channels. When used together, their effects are additive or synergistic, leading to a high risk of severe bradycardia and high-degree AV block.

Question 11

A 72-year-old patient on metoprolol succinate for heart failure and verapamil for atrial fibrillation is admitted with lightheadedness and a heart rate of 35 bpm. The electrocardiogram shows a third-degree atrioventricular (AV) block. This severe adverse event is a result of the synergistic effects of these two drugs on which physiological process?

  1. Inhibition of the funny current (If) in the sinoatrial node.
  2. Blockade of fast sodium channels in ventricular myocytes.
  3. Suppression of calcium influx and conduction velocity in the AV node. (correct answer)
  4. Potentiation of vagal tone at the sinoatrial node.
Explanation: Both beta-blockers (like metoprolol) and non-dihydropyridine calcium channel blockers (like verapamil) suppress AV nodal conduction. Beta-blockers do this by decreasing cAMP, which reduces calcium current. Verapamil directly blocks L-type calcium channels. When used together, their effects are additive or synergistic, leading to a high risk of severe bradycardia and high-degree AV block.

Question 12

A 75-year-old male with hypertension, chronic obstructive pulmonary disease (COPD), and peripheral vascular disease is considered for beta-blocker therapy. Which agent would be the most appropriate initial choice to minimize potential adverse effects related to his comorbidities?

  1. Propranolol
  2. Nadolol
  3. Metoprolol (correct answer)
  4. Labetalol
Explanation: In a patient with COPD and peripheral vascular disease, a beta-1 selective ('cardioselective') antagonist is preferred. Propranolol, nadolol, and labetalol are all non-selective beta-blockers, meaning they also block beta-2 receptors. Beta-2 blockade can cause bronchoconstriction (worsening COPD) and vasoconstriction in peripheral arteries (worsening peripheral vascular disease). Metoprolol's relative selectivity for beta-1 receptors minimizes these risks.

Question 13

A patient is started on a new medication for hypertension. He reports persistent nasal congestion, postural dizziness, and an occasional racing heartbeat. This cluster of adverse effects is most characteristic of which class of antihypertensive agents?

  1. Beta-1 selective antagonists
  2. Alpha-1 selective antagonists (correct answer)
  3. Central alpha-2 agonists
  4. Thiazide diuretics
Explanation: This constellation of symptoms points directly to alpha-1 blockade. Blockade of alpha-1 receptors in venous and arterial smooth muscle leads to vasodilation, causing postural dizziness. The vasodilation in nasal mucosa causes congestion. The drop in blood pressure triggers a baroreceptor-mediated reflex tachycardia, causing a 'racing heartbeat.'

Question 14

A 45-year-old patient with type 1 diabetes and essential hypertension is prescribed propranolol. Which of the following represents the most significant acute risk for this specific patient related to the medication's mechanism of action?

  1. Development of hyperosmolar hyperglycemic state due to impaired insulin release.
  2. Masking of neurogenic warning symptoms of hypoglycemia, such as tachycardia and tremors. (correct answer)
  3. Potentiation of metformin's action, leading to an increased risk of lactic acidosis.
  4. Worsening of diabetic nephropathy due to reduced renal blood flow.
Explanation: Non-selective beta-blockers like propranolol block the adrenergic response to hypoglycemia. Symptoms like tachycardia, palpitations, and tremors, which serve as crucial warning signs for a diabetic patient, are blunted. While sweating (a cholinergic symptom) is preserved, the loss of other key symptoms increases the risk of severe, unrecognized hypoglycemic episodes.

Question 15

A patient in anaphylactic shock receives an intravenous injection of epinephrine, which increases their blood pressure from 70/40 mmHg to 140/90 mmHg. If a non-selective alpha-adrenergic antagonist like phentolamine is then administered, what is the most probable effect on the patient's blood pressure?

  1. A further increase in systolic blood pressure due to reflex tachycardia.
  2. A decrease in diastolic pressure but a maintained or increased systolic pressure.
  3. A profound decrease in blood pressure, potentially falling below the initial baseline. (correct answer)
  4. Stabilization of blood pressure near the pre-epinephrine baseline of 70/40 mmHg.
Explanation: This scenario describes 'epinephrine reversal'. Epinephrine stimulates alpha-1, beta-1, and beta-2 receptors. The alpha-1 stimulation causes vasoconstriction (increasing BP), while beta-2 stimulation causes vasodilation (decreasing BP). After an alpha-blocker is given, the alpha-1 vasoconstrictor effect is blocked, leaving the beta-2 vasodilator effect unopposed. This results in a significant drop in blood pressure.

Question 16

A 68-year-old patient with heart failure with reduced ejection fraction (HFrEF) is being treated with carvedilol. Compared to a beta-1 selective antagonist like metoprolol succinate, what additional hemodynamic benefit does carvedilol provide in this patient population?

  1. Greater reduction in heart rate due to higher affinity for beta-1 receptors.
  2. Afterload reduction through blockade of vascular alpha-1 receptors. (correct answer)
  3. Prevention of bradycardia through intrinsic sympathomimetic activity.
  4. Enhanced renal perfusion by blocking beta-2 receptors in the kidney.
Explanation: Carvedilol is a non-selective beta-blocker that also possesses alpha-1 blocking activity. This alpha-1 antagonism leads to vasodilation, which reduces systemic vascular resistance (afterload). This reduction in afterload decreases the work the failing heart must do to eject blood, providing a hemodynamic advantage over beta-blockers that lack this property, like metoprolol.

Question 17

A 30-year-old pregnant patient at 32 weeks gestation presents with a blood pressure of 180/115 mmHg and is diagnosed with a hypertensive emergency. Intravenous labetalol is administered. The therapeutic advantage of labetalol in this setting stems from its ability to:

  1. selectively block beta-1 receptors, lowering cardiac output without affecting uterine tone.
  2. decrease systemic vascular resistance via alpha-1 blockade while preventing reflex tachycardia via beta-blockade. (correct answer)
  3. act as a direct-acting arterial vasodilator, bypassing adrenergic receptors entirely.
  4. stimulate central alpha-2 receptors, reducing sympathetic outflow from the brainstem.
Explanation: Labetalol is a mixed antagonist with a blocking ratio of approximately 1:7 for alpha-1 to beta receptors after IV administration. The alpha-1 blockade causes vasodilation, lowering systemic vascular resistance and blood pressure. The simultaneous beta-blockade (both beta-1 and beta-2) prevents the baroreceptor-mediated reflex tachycardia that would typically occur with a pure vasodilator, making it an effective and hemodynamically stable choice in hypertensive emergencies.

Question 18

A 70-year-old male with benign prostatic hyperplasia (BPH) is prescribed tamsulosin. He experiences significant improvement in urinary flow with minimal dizziness or changes in blood pressure. This clinical effect profile is best explained by tamsulosin's relative selectivity for which receptor subtype?

  1. Alpha-1A receptors located in prostatic smooth muscle. (correct answer)
  2. Alpha-1B receptors located in vascular smooth muscle.
  3. Alpha-2A receptors that regulate neurotransmitter release.
  4. Beta-2 receptors in the bladder detrusor muscle.
Explanation: The alpha-1 adrenergic receptor has subtypes. Alpha-1A receptors are predominantly found in the smooth muscle of the prostate and bladder neck. Alpha-1B receptors are more prevalent in vascular smooth muscle. Tamsulosin is selective for the alpha-1A subtype, allowing it to relax prostatic smooth muscle and improve urinary flow with less effect on blood vessels, thus minimizing orthostatic hypotension compared to non-selective alpha-1 blockers like prazosin.

Question 19

A patient is started on a new medication for hypertension. He reports persistent nasal congestion, postural dizziness, and an occasional racing heartbeat. This cluster of adverse effects is most characteristic of which class of antihypertensive agents?

  1. Beta-1 selective antagonists
  2. Alpha-1 selective antagonists (correct answer)
  3. Central alpha-2 agonists
  4. Thiazide diuretics
Explanation: This constellation of symptoms points directly to alpha-1 blockade. Blockade of alpha-1 receptors in venous and arterial smooth muscle leads to vasodilation, causing postural dizziness. The vasodilation in nasal mucosa causes congestion. The drop in blood pressure triggers a baroreceptor-mediated reflex tachycardia, causing a 'racing heartbeat.'

Question 20

A 59-year-old male with hypertension has been treated with metoprolol tartrate for five years. His recent fasting lipid panel reveals a triglyceride level of 250 mg/dL and an HDL level of 35 mg/dL. These findings represent a known metabolic adverse effect pattern associated with beta-blocker therapy. Which subset of beta-antagonists is most strongly associated with these particular lipid abnormalities?

  1. Agents with intrinsic sympathomimetic activity like pindolol.
  2. Beta-1 selective antagonists like metoprolol.
  3. Alpha-1 and beta-antagonists like carvedilol.
  4. Non-selective beta-antagonists like propranolol. (correct answer)
Explanation: When you encounter questions about beta-blocker side effects, remember that different subtypes of beta-antagonists have distinct metabolic profiles, particularly regarding lipid metabolism. The patient's lipid abnormalities—elevated triglycerides (250 mg/dL) and low HDL (35 mg/dL)—represent a classic adverse metabolic pattern. This occurs because beta-2 receptors normally promote lipolysis and help maintain favorable lipid profiles. When these receptors are blocked, triglyceride clearance decreases and HDL levels drop. Non-selective beta-antagonists like propranolol (D) block both beta-1 and beta-2 receptors throughout the body. The beta-2 blockade in adipose tissue and liver significantly impairs lipid metabolism, making this class most strongly associated with the described lipid abnormalities. This is the correct answer. Looking at the distractors: (A) Agents with intrinsic sympathomimetic activity like pindolol actually have less pronounced metabolic effects because they provide partial beta-receptor stimulation, somewhat offsetting the negative lipid effects. (B) Beta-1 selective antagonists like metoprolol (ironically, what this patient is taking) primarily affect cardiac beta-1 receptors and have minimal impact on beta-2-mediated lipid metabolism. (C) Alpha-1 and beta-antagonists like carvedilol often improve lipid profiles due to their alpha-blocking properties, which can enhance insulin sensitivity. Study tip: Remember the selectivity spectrum—the more non-selective the beta-blocker (especially affecting beta-2 receptors), the greater the risk of metabolic side effects. Always consider switching to beta-1 selective agents or those with additional alpha-blocking properties when lipid abnormalities develop.